Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a first-in-human phase I/II randomized, double-blind, placebo (vehicle)-controlled, multicenter study to assess the Safety and Efficacy of AVX-012 Ophthalmic Solution in subjects with Mild-to-Moderate Dry Eye Syndrome. The study consists of two parts (part A and part B):
Epistemonikos ID: 80546d46bdd2a57d58ef874b72b1ef2594008da3
First added on: May 20, 2024